NP1054002.RAuXyvbUvAXRdyBLISkzVd 9iVnNPt-HJbdzV64SB-rK4
type: Nanopublication
has assertion: NP1054002.RAuXyvbUvAXRdyBLISkzVd 9iVnNPt-HJbdzV64SB-rK4130 assertion
has provenance: NP1054002.RAuXyvbUvAXRdyBLISkzVd 9iVnNPt-HJbdzV64SB-rK4130 provenance
has publication info: NP1054002.RAuXyvbUvAXRdyBLISkzVd 9iVnNPt-HJbdzV64SB-rK4130 publicationInfo
created: 2016-05-13T12:49:44+02:00
rights: http://opendatacommons.org/licenses/odbl/1.0/
rights holder: IBIGroup
subject: SIO_000983
used data: disgenetv3.0rdf
authored by: http://orcid.org/0000-0001-5999-6269
authored by: http://orcid.org/0000-0002-7534-7661
authored by: 0000-0002-9383-528X
authored by: http://orcid.org/0000-0003-0169-8159
authored by: http://orcid.org/0000-0003-1244-7654
created by: http://orcid.org/0000-0003-0169-8159
version: v4.0.0.0

NP1054002.RAuXyvbUvAXRdyBLISkzVd 9iVnNPt-HJbdzV64SB-rK4130 assertion
type: Assertion
description: [Of the 31 patients in remission at 12 months post-HCT, disease-free survival was 86% in patients with MRD <10(-4) and 20% in those with MRD ≥10(-4) (relapse hazard ratio (HR) 9.0; 95% confidence interval (CI) 2.5-32; P<0.0001), with median follow-up of 36 months.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine.
evidence: DisGeNET evidence - LITERATURE
SIO_000772: http://identifiers.org/pubmed/23419792
was generated by: ECO_0000203

befree-2016
imported on: 2016-02-19

DisGeNET evidence - LITERATURE
type: ECO_0000212
comment: Gene-disease associations inferred from text-mining the literature.

disgenetv3.0rdf
version: v4.0.0